Home | Publications | Research (R&D) | Pipeline place holder
place holder place holder

Pipeline

Gen-Probe Incorporated Product Pipeline Analysis


Publication Date   August 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   64
ISBN Number   not applicable
Product Code   GMD643
Ask a question about this product?

Price £505.00

approximately: $753 | €602

Summary


This report is an insightful source for data, analysis and strategic insights into a Gen-Probe Incorporated's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content


  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
    • 2.4 Industry Outlook - In Vitro Diagnostics
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Clinical Diagnostics and Blood Screening products
      • 3.2.1 Overview
      • 3.2.2 Financials
      • 3.2.3 Market View
      • 3.2.4 Key Strategies
    • 3.3 Major Products and Services
      • 3.3.1 Overview
  • 4 History
  • 5 BUSINESS STRATEGY
    • 5.1 Mission Statement
    • 5.2 Strategy
    • 5.3 Corporate Social Responsibility
      • 5.3.1 Overview
  • 6 VALUE CHAIN ANALYSIS
    • 6.1 Manufacturing
      • 6.1.1 In House Manufacturing
      • 6.1.2 Outsourcing
    • 6.2 Product Development
      • 6.2.1 Regulatory Approvals
      • 6.2.2 Clinical Trials
      • 6.2.3 Research and Development
    • 6.3 Sales and Marketing
      • 6.3.1 Partnerships and Alliances
      • 6.3.2 Licensing Agreements
  • 7 Competitors
  • 8 Share Holding Structure
  • 9 Key Employees
  • 10 Key Employee Biographies
  • 11 Company Statement
  • 12 Locations And Subsidiaries
    • 12.1 Head Office
  • 13 Recent Developments
    • 13.1 Strategy And Business Planning
      • 13.1.1 Jun 17, 2008: 3M Ends Staph-Screening Partnership With Gen-Probe
      • 13.1.2 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid Molecular Tests
    • 13.2 Financial Announcements
      • 13.2.1 Jul 31, 2008: Gen-Probe Declares 2Q 2008 Results
      • 13.2.2 Apr 28, 2008: Gen-Probe Declares Q1 2008 Results
      • 13.2.3 Apr 10, 2008: Gen-Probe To Declare Q1 2008 Results
      • 13.2.4 Oct 30, 2007: Gen-Probe Reports Q3 2007 Results
      • 13.2.5 Aug 01, 2007: Gen-Probe Declares Q2 2007 Results
      • 13.2.6 May 01, 2007: Gen-Probe Declares Q1 2007 Results
      • 13.2.7 Feb 13, 2007: Gen-Probe Declares Q4 2006 Results
      • 13.2.8 Feb 13, 2007: Gen-Probe Declares Q4 2007 Results
    • 13.3 Corporate Communications
      • 13.3.1 May 19, 2008: Gen-Probe Elects New Board Member
      • 13.3.2 Feb 11, 2008: Gen-Probe Appoints President
      • 13.3.3 Feb 11, 2008: Gen-Probe Appoints COO
      • 13.3.4 Nov 19, 2007: Gen-Probe Appoints VP, Operations
      • 13.3.5 Sep 20, 2007: Gen-Probe Elects New Board Member
      • 13.3.6 Feb 13, 2007: Gen-Probe COO To Join
    • 13.4 Product News
      • 13.4.1 Aug 13, 2008: FDA Grants Full Approval Of PROCLEIX ULTRIO Blood Screening Assay
      • 13.4.2 May 28, 2008: Gen-Probe Launches In Europe CE-Marked APTIMA HPV Assay For Detection Of Human Papillomavirus
      • 13.4.3 Apr 01, 2008: Gen-Probe Begins US Clinical Study Of Molecular Test For Human Papillomavirus
      • 13.4.4 Mar 19, 2008: New Study Backs Use Of Gene-Based Urine Test In Prostate Cancer
      • 13.4.5 Feb 21, 2008: Gen-Probe Submits US Regulatory Application For Additional Approval Of PROCLEIX
      • 13.4.6 Apr 30, 2007: 3M, Gen-Probe Form Collaboration To Develop Rapid Molecular Tests To Combat Healthcare-Associated Infections
      • 13.4.7 Mar 29, 2007: Promising Data On Molecular Research Test For Prostate Cancer Published In Peer-Reviewed Journal UROLOGY
      • 13.4.8 Jan 29, 2007: Gen-Probe Reports Positive Regulatory Progress for PROCLEIX ULTRIO Blood Screening Assay on the TIGRIS System
      • 13.4.9 Nov 22, 2006: New, Highly Specific Gene-Based Test For Prostate Cancer Introduced In Europe
      • 13.4.10 Feb 25, 2005: Gen-Probe Signs Agreement With Roche To Purchase Products For APTIMA Human Papillomavirus Assay
    • 13.5 Product Approvals
      • 13.5.1 Aug 13, 2008: FDA Grants Full Approval Of PROCLEIX ULTRIO Blood Screening Assay
    • 13.6 Clinical Trials
      • 13.6.1 Apr 01, 2008: Gen-Probe Begins US Clinical Study Of Molecular Test For Human Papillomavirus
      • 13.6.2 Mar 19, 2008: New Study Backs Use Of Gene-Based Urine Test In Prostate Cancer
  • 14 Gen-Probe Incorporated Pipeline Products
    • 14.1 Gen-Probe Incorporated Product Pipeline Analysis
      • 14.1.1 Gen-Probe Incorporated Pipeline Products By Equipment Type
      • 14.1.2 Gen-Probe Incorporated Pipeline Products By Development Stage
      • 14.1.3 Gen-Probe Incorporated Pipeline Products By Therapy Area
      • 14.1.4 Gen-Probe Incorporated Pipeline Products By Clinical Trials
      • 14.1.5 Gen-Probe Incorporated Pipeline Products By News Summary
    • 14.2 APTIMA HPV Assay
      • 14.2.1 Product Description
      • 14.2.2 Product Status
      • 14.2.3 Clinical Trials
      • 14.2.4 Product Milestone
    • 14.3 PROGENSA PCA3 Assay
      • 14.3.1 Product Description
      • 14.3.2 Product Status
      • 14.3.3 Clinical Trials
      • 14.3.4 Product Milestone
    • 14.4 Panther System
      • 14.4.1 Product Description
      • 14.4.2 Product Status
    • 14.5 PROCLEIX ULTRIO assay for hepatitis B virus
      • 14.5.1 Product Description
      • 14.5.2 Product Status
      • 14.5.3 Product Milestone
    • 14.6 Methicillin-resistant Staphylococcus aureus nucleic acid test
      • 14.6.1 Product Description
      • 14.6.2 Product Status
      • 14.6.3 Product Milestone
  • 15 Appendix
    • 15.1 Methodology
      • 15.1.1 Coverage
      • 15.1.2 Secondary Research
      • 15.1.3 Primary Research
      • 15.1.4 Expert Panel Validation
    • 15.2 Contact Us
    • 15.3 About Global Markets Direct
    • 15.4 Disclaimer
  • 1 List of Tables
    • Table 1: Gen-Probe Incorporated,Key Facts, 2007
    • Table 2: Gen-Probe Incorporated, Share Holding Structure
    • Table 3: Gen-Probe Incorporated, Key Employees, 2007
    • Table 4: Gen-Probe Incorporated Pipeline Products by Equipment Type
    • Table 5: Gen-Probe Incorporated Pipeline Products By Development Stage
    • Table 6: Gen-Probe Incorporated Pipeline Products By Therapy Area
    • Table 7: Gen-Probe Incorporated Pipeline Products By Clinical Trials
    • Table 8: Gen-Probe Incorporated Pipeline Products By News Summaries
    • 1.2 List of Figures
    • Figure 1: Gen-Probe Incorporated, Value Chain Analysis
    • Figure 2: Gen-Probe Incorporated Pipeline Products By Equipment Type
    • Figure 3: Gen-Probe Incorporated Pipeline Products By Equipment Type
    • Figure 4: Gen-Probe Incorporated Pipeline Products By Development Stage
    • Figure 5: Gen-Probe Incorporated Pipeline Products By News Summary
    • Figure 6: Global Markets Direct Methodology